Ender Kalaci

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.

Journal: Clinical genitourinary cancer
Published: May 03, 2026

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 01, 2026

Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study.

Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study.

Journal: Medicine
Published: January 29, 2025

Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis.

Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis.

Journal: Medicina (Kaunas, Lithuania)
Published: December 24, 2024

Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience.

Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience.

Journal: Journal of chemotherapy (Florence, Italy)
Published: May 28, 2024

Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient.

Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 04, 2023

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer.

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer.

Journal: Tuberkuloz ve toraks
Published: July 05, 2022

Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: April 30, 2021

Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: April 30, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026